Meghan Green Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3443 S 55th Ave, Cicero, IL 60804 Phone: 708-780-0822 |
Jennifer Favela, MS, CCC, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3632 S 57th Ave, Cicero, IL 60804 Phone: 773-593-0370 |
Cristina Garza, MS. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1925 S Austin Blvd, Cicero, IL 60804 Phone: 708-595-4569 |
Sarah Elizabeth Grote Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5825 W Cermak Rd, Cicero, IL 60804 Phone: 708-656-9120 |
Randy Blaszczyk, CCC-SLP/L Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2423 S Austin Blvd, Cicero, IL 60804 Phone: 708-780-2800 |
Melissa Zbinden, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5425 W 31st St, Cicero, IL 60804 Phone: 708-652-1144 |
Liliana Alejandra Herrera, MA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 3540 S 58th Ct, Cicero, IL 60804 Phone: 708-291-0576 |
Miss Courtney Flood, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5330 W 35th St, Cicero, IL 60804 Phone: 630-400-7852 |
News Archive
Duke University Medical Center researchers have discovered that patients who have two specific gene variants are more than three times as likely to suffer a stroke after heart surgery.
An Orange County Superior Court Judge has certified a class action against Abbott Medical Optics, Inc., on behalf of all California consumers who purchased a contact lens solution the Centers for Disease Control have linked to a parasitic infection that can cause blindness or the complete loss of an eye.
EuroPCR 2017, the official annual meeting of the European Association for Percutaneous Cardiovascular Interventions, pushed back barriers in bringing together young and established interventional cardiologists to learn from past successes, build understanding and experience of new percutaneous interventional approaches, and develop innovations for the future at this year's course held from 16 to 19 May 2017 at the Palais des Congrès in Paris, France.
ImmunoCellular Therapeutics, Ltd., a biotechnology company that is developing immune based therapies for the treatment of various forms of cancer, announced today it received a Notice of Allowance from the United States Patent and Trademark Office covering technology relating to monoclonal antibodies that bind to certain epitopes present on pancreatic cancers. This patent will broaden the Company's proprietary intellectual property for ICT-109 and ICT-37, two of the Company's monoclonal antibody product candidates.
› Verified 9 days ago